You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TILADE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TILADE?
  • What are the global sales for TILADE?
  • What is Average Wholesale Price for TILADE?
Summary for TILADE
Drug patent expirations by year for TILADE
Recent Clinical Trials for TILADE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CAMP Steering CommitteePhase 3
Johns Hopkins Bloomberg School of Public HealthPhase 3
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all TILADE clinical trials

US Patents and Regulatory Information for TILADE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us TILADE nedocromil sodium SOLUTION;INHALATION 020750-001 Oct 1, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TILADE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 ⤷  Sign Up ⤷  Sign Up
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TILADE

See the table below for patents covering TILADE around the world.

Country Patent Number Title Estimated Expiration
France 2563105 COMPOSITIONS POUR LES SOINS DES VOIES RESPIRATOIRES ⤷  Sign Up
Spain 8707222 PROCEDIMIENTO PARA LA OBTENCION DEL 9-ETIL-4,6-DIOXO-10-PROPIL-6,9-DIHIDRO-4H-PIRANO(3,2-G)QUINOLINA-2,8-DICARBOXILATO DE DIETILO (Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate) ⤷  Sign Up
Japan H01199909 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRANOQUINOLINE DERIVATIVE ⤷  Sign Up
Luxembourg 79579 ⤷  Sign Up
United Kingdom 2022078 ⤷  Sign Up
Netherlands 184896 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.